Literature DB >> 32547681

Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors.

Jie Wang1, Wei-Wei Hu2, Zhi Jiang1, Mei-Jiang Feng1.   

Abstract

Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis, are a group of incurable neurological disorders, characterized by the chronic progressive loss of different neuronal subtypes. However, despite its increasing prevalence among the ever-increasing aging population, little progress has been made in the coincident immense efforts towards development of therapeutic agents. Research interest has recently turned towards stem cells including stem cells-derived exosomes, neurotrophic factors, and their combination as potential therapeutic agents in neurodegenerative diseases. In this review, we summarize the progress in therapeutic strategies based on stem cells combined with neurotrophic factors and mesenchymal stem cells-derived exosomes for neurodegenerative diseases, with an emphasis on the combination therapy. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Brain-derived neurotrophic factor; Combination therapy; Glial cell line-derived neurotrophic factor; Nerve growth factor; Neurodegenerative diseases; Stem cells

Year:  2020        PMID: 32547681      PMCID: PMC7280867          DOI: 10.4252/wjsc.v12.i5.323

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  103 in total

Review 1.  Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Authors:  Tiago Martins Rodrigues; André Jerónimo-Santos; Tiago Fleming Outeiro; Ana Maria Sebastião; Maria José Diógenes
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

Review 2.  Mesenchymal stem cells for the treatment of neurodegenerative disease.

Authors:  Nanette Joyce; Geralyn Annett; Louisa Wirthlin; Scott Olson; Gerhard Bauer; Jan A Nolta
Journal:  Regen Med       Date:  2010-11       Impact factor: 3.806

3.  GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.

Authors:  D B Hoban; L Howard; E Dowd
Journal:  Neuroscience       Date:  2015-07-10       Impact factor: 3.590

4.  2016 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2016-04       Impact factor: 21.566

Review 5.  Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery.

Authors:  J Simon Lunn; Michael P Hefferan; Martin Marsala; Eva L Feldman
Journal:  Growth Factors       Date:  2009-06       Impact factor: 2.511

6.  Effects of lateral ventricular transplantation of bone marrow-derived mesenchymal stem cells modified with brain-derived neurotrophic factor gene on cognition in a rat model of Alzheimer's disease.

Authors:  Ping Zhang; Gangyong Zhao; Xianjiang Kang; Likai Su
Journal:  Neural Regen Res       Date:  2012-02-05       Impact factor: 5.135

7.  Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer's disease.

Authors:  Edwin E Reza-Zaldivar; Mercedes A Hernández-Sapiéns; Yanet K Gutiérrez-Mercado; Sergio Sandoval-Ávila; Ulises Gomez-Pinedo; Ana L Márquez-Aguirre; Estefanía Vázquez-Méndez; Eduardo Padilla-Camberos; Alejandro A Canales-Aguirre
Journal:  Neural Regen Res       Date:  2019-09       Impact factor: 5.135

8.  Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.

Authors:  Kari Pollock; Heather Dahlenburg; Haley Nelson; Kyle D Fink; Whitney Cary; Kyle Hendrix; Geralyn Annett; Audrey Torrest; Peter Deng; Joshua Gutierrez; Catherine Nacey; Karen Pepper; Stefanos Kalomoiris; Johnathon D Anderson; Jeannine McGee; William Gruenloh; Brian Fury; Gerhard Bauer; Alexandria Duffy; Theresa Tempkin; Vicki Wheelock; Jan A Nolta
Journal:  Mol Ther       Date:  2016-01-14       Impact factor: 11.454

9.  ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation.

Authors:  Tina Zimmermann; Floortje Remmers; Beat Lutz; Julia Leschik
Journal:  Stem Cell Reports       Date:  2016-09-29       Impact factor: 7.765

10.  The Anti-Apoptotic Effect of ASC-Exosomes in an In Vitro ALS Model and Their Proteomic Analysis.

Authors:  Roberta Bonafede; Jessica Brandi; Marcello Manfredi; Ilaria Scambi; Lorenzo Schiaffino; Flavia Merigo; Ermanna Turano; Bruno Bonetti; Emilio Marengo; Daniela Cecconi; Raffaella Mariotti
Journal:  Cells       Date:  2019-09-14       Impact factor: 6.600

View more
  6 in total

Review 1.  Insights of Extracellular Vesicles of Mesenchymal Stem Cells: a Prospective Cell-Free Regenerative Medicine for Neurodegenerative Disorders.

Authors:  P Vatsa; R Negi; U A Ansari; V K Khanna; A B Pant
Journal:  Mol Neurobiol       Date:  2021-10-29       Impact factor: 5.682

Review 2.  New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease.

Authors:  Feng Zhang; Ru-Jia Zhong; Cheng Cheng; Song Li; Wei-Dong Le
Journal:  Acta Pharmacol Sin       Date:  2020-12-02       Impact factor: 7.169

3.  Local continuous glial cell derived neurotrophic factor release using osmotic pump promotes parasympathetic nerve rehabilitation in an animal model of cavernous nerve injury induced erectile dysfunction.

Authors:  Huixi Li; Zhichao Zhang; Dong Fang; Yuan Tang; Jing Peng
Journal:  Transl Androl Urol       Date:  2021-01

Review 4.  Motor neuron replacement therapy for amyotrophic lateral sclerosis.

Authors:  Bochao Liu; Mo Li; Lingyan Zhang; Zhiguo Chen; Paul Lu
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

Review 5.  Update on the application of mesenchymal stem cell-derived exosomes in the treatment of Parkinson's disease: A systematic review.

Authors:  Shu-Fen Liu; Lin-Yi Li; Jian-Long Zhuang; Mi-Mi Li; Li-Chao Ye; Xiang-Rong Chen; Shu Lin; Chun-Nuan Chen
Journal:  Front Neurol       Date:  2022-10-03       Impact factor: 4.086

6.  A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies.

Authors:  Heather Dahlenburg; David Cameron; Sheng Yang; Angelica Bachman; Kari Pollock; Whitney Cary; Missy Pham; Kyle Hendrix; Jeannine White; Haley Nelson; Peter Deng; Joseph S Anderson; Kyle Fink; Jan Nolta
Journal:  Stem Cells Transl Med       Date:  2021-03-12       Impact factor: 6.940

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.